PeptideStack
5.2kquestions
20kanswers
220users

Why did my magnesium move after twelve weeks on dulaglutide?

Asked 11 Oct 2025Modified 8 months agoViewed 6.3k times
22

Setup, so nobody has to ask: magnesium · twelve weeks · dulaglutide.

I have two candidate explanations and no way to distinguish them.

The same procedure has worked without incident several times previously, which argues against technique.

Should I be treating this as a failure or as noise?

bloodwork
bloodwork

Laboratory monitoring: which panels are worth ordering, sensible intervals, reference-range versus optimal-range arguments, and how to read a…

296 questions
kidney-function
kidney-function

eGFR, creatinine, cystatin C and albuminuria: the acute haemodynamic dip that is not injury, the renal outcome data from the FLOW programme, and…

141 questions
lipids
lipids

Lipid response on treatment: triglycerides, LDL-C, non-HDL-C, ApoB and Lp(a), which of them move with weight loss, and why a fasting panel drawn…

139 questions
electrolytes
electrolytes

Sodium, potassium and magnesium during reduced intake and GI losses: what the symptoms of a shortfall look like, when a panel is worth drawing,…

72 questions
dulaglutide
dulaglutide

A once-weekly GLP-1 receptor agonist built on an Fc fusion rather than fatty-acid acylation. Use this tag for questions about the fusion-protein…

200 questions
shareeditfollowflag
AP
askedarea_percent9.9k1611 Oct 2025
8Is there a repeat draw, or is this a single value? One value is a point, not a trend. – fib4_reader 3 months ago
7Which equation produced the eGFR? They disagree by enough to matter at the margins. – Dr_Malik_Osei 43 days ago
add a comment

4 Answers

Accepted answer first, then by votes
34

Accepted answer

12 weeks is 84 days, and the first question about any marker is whether 84 days is long enough for it to have finished moving. Serum magnesium represents about one per cent of body magnesium, which is why it can sit mid-range while intake has been inadequate for months. Against 84 days that puts the marker well inside its own settling time, so the value is reporting a new steady state rather than a transient. The second question is the denominator. Weight loss moves plasma volume, muscle mass and intake at once, and several of the markers on a routine panel are ratios with one of those three underneath them. Repeat before interpreting. A single value 84 days in, with no baseline drawn under the same conditions, is a number rather than a change — and nothing here is medical advice.

Start with a baseline. A result taken before anything started converts most later ambiguity into a simple comparison, and it cannot be obtained retrospectively.

Same laboratory, same method, same time of day, same fasting state. Between-laboratory differences on several common analytes are larger than the changes people are trying to detect.

Keep the reports rather than the numbers. Units, reference intervals and methods all vary, and a bare number two years later is not comparable to anything.

Biological variation data are published per analyte and are the basis for the reference change value — the difference between two results that is larger than noise.

Ordering tests you will not act on generates anxiety and incidental findings, both of which have costs.

Decide the action for each result before you order the test.

shareimprove this answerflag
DA
answered · acceptedDr_Rosalind_Achebe69k1474 Nov 2025
Minor: haemolysis inflates potassium enough to cause a fright over what is a handling artefact. – bea_castellanos 8 months ago
Adding a vote because this deserves more of them. – dmitri_savchuk 6 months ago
add a comment
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results
40

The honest position is that most people order too many analytes and too few time points, when the reverse would be more informative.

A sensible core for this population is a full blood count, renal function with electrolytes, liver enzymes with bilirubin, a fasting lipid panel with apolipoprotein B, HbA1c and thyroid-stimulating hormone.

Repeat before you react. A single abnormal value has a substantial probability of being within the combined biological and analytical variation of a normal one.

Keep the full report, not the number. You will need the units and the interval later.

edited 8 Dec 2025 by Dr_Wren_Halliday — fixed an arithmetic slip in the third paragraph

shareimprove this answerflag
DH
answeredDr_Wren_Halliday19k3726 Nov 2025
6Worth flagging that a mild enzyme elevation with a normal bilirubin is a different object from a rising one. – Dr_Yusuf_Adeyemi 2 months ago
7The one-in-twenty out-of-range arithmetic should be printed at the top of every panel report. – loss_on_drying 3 months ago
add a comment
26

The relevant statistical point is that a ninety-five per cent reference interval means one analyte in twenty will read out of range in a healthy person by construction.

Timing matters per analyte: cortisol and testosterone are diurnal, triglycerides are postprandial, and creatinine responds to hydration and to recent training. Fixing the conditions removes most of the noise.

A twenty-analyte panel run on a healthy person will produce, on average, one out-of-range result purely from how reference intervals are constructed. That is arithmetic rather than pathology.

Baseline first, then a repeat under identical conditions. Everything else is secondary.

shareimprove this answerflag
ID
answeredimani_dube8.9k157 Dec 2025
15

The short version: a small, well-chosen panel with a baseline beats a large one without.

Haemolysis in the sample raises potassium and several enzymes spuriously. If a result is bizarre, ask whether the sample was flagged before building a theory on it.

Same laboratory, same time, same fasting state, or the comparison is not a comparison.

shareimprove this answerflag
ID
answeredimani_dube8.9k1515 Nov 2025
4Same experience here, different supplier. – gel_pack_warm 7 months ago
add a comment

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.